Effect mono-ADP-ribosylation on lipid metabolism of colorectal cancer by regulating IGFBP1 methylation

Author:

Wang ChuanLing1,Tang Yi1,Zhang ShuXian1,Xiao Ming1,Li Ming1,Yang Lian1,Li QingShu1,Li Xian1,Wang YaLan1

Affiliation:

1. School of Basic Medicine, Chongqing Medical University

Abstract

AbstractIn the global health community, colon cancer (CRC) is a major concern, with a high rate of incidence. Epigenetics is recognized as one of the causes of CRC development and progression. Mono-ADP-ribosylation (MARylation) is a type of epigenetics, although the modification level and the target protein in CRC remain unclear. We previously reported that the MARylation of arginine-117 of histone 3 (H3R117) promotes the proliferation, upregulates methylation of tumor suppressor gene, and is tightly associated with the metabolic processes in LoVo cells. Lipid metabolism disorder is involved in the development of CRC at the early stage. Our study revealed that MARylation of H3R117 of the LoVo cells modulated lipid metabolism, increased cholesterol synthesis, promoted lipid raft (LR) protein IGF-1R distribution, and inhibited cell apoptosis through IGFBP1. In addition, bioinformatics analyses revealed that the IGFBP1 promoter was hypermethylated in CRC when compared to that in normal tissues. Moreover, H3R117 MARylation upregulated the methylation of IGFBP1 promoter through histone H3 citrullination (H3cit) by increasing the H3K9me2, heterochromatin protein1 (HP1), and DNA methyltransferase 1 (DNMT1) enrichment of IGFBP1 promoter. Accordingly, IGFBP1 may function as a tumor suppressor gene, while H3R117 MARylation may promote CRC development. Our study findings enrich the available data on epigenetics of CRC and provide a new idea and experimental basis for H3R117 MARylation as a target in CRC treatment.

Publisher

Research Square Platform LLC

Reference55 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA: a cancer journal for clinicians,2021

2. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia C;Chin Med J (Engl),2022

3. PARPs and ADP-ribosylation: 60 years on;Kraus W;Genes Dev,2020

4. Lüscher, B., et al., ADP-ribosyltransferases, an update on function and nomenclature. FEBS J, 2021.

5. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2;Li M;Oncogene,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3